Patenting genes and theranostics including HGS v Lilly
Developments in European patent law in the last 12 months
Product launch strategies and preliminary injunctions including the Solvay case
Dealing with competition law issues in patenting
The Unified Patent Court – what will the impact be?
Planning for patent expiry and managing innovation
Strategies for maximising patent life cycles - exploring the application of SPCs to extend patents
SPCs masterclass - recent case law and varying requirements around Europe including an analysis of the impact of Neurim
Who should Attend
Patent Attorneys and Agents
Biotech and Pharma Companies: In-house Counsel, Patent Attorneys, IP Managers, Legal Advisors, Patent Advisors, Chief IP Counsel, IP Directors, Scientific Researchers, CEOs and Corporate Management
Intellectual Property Consultants
Intellectual Property Lawyers
Academics
Examiners
Past Events
23rd Annual Biotech & Pharmaceutical Patenting 2015 - 24-25 Feb 2015, Vier Jahreszeiten Kempinski Hotel, Munich, Germany (40936)
